Quantum Biopharma Stock Probability of Future Stock Price Finishing Over 11.75
| QNTM Stock | 3.84 0.17 4.24% |
Quantum |
Quantum BioPharma Target Price Odds to finish over 11.75
The tendency of Quantum Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over 11.75 or more in 90 days |
| 3.84 | 90 days | 11.75 | near 1 |
Based on a normal probability distribution, the odds of Quantum BioPharma to move over 11.75 or more in 90 days from now is near 1 (This Quantum BioPharma probability density function shows the probability of Quantum Stock to fall within a particular range of prices over 90 days) . Probability of Quantum BioPharma price to stay between its current price of 3.84 and 11.75 at the end of the 90-day period is about 85.52 .
Given the investment horizon of 90 days Quantum BioPharma has a beta of 0.82 indicating as returns on the market go up, Quantum BioPharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Quantum BioPharma will be expected to be much smaller as well. Additionally Quantum BioPharma has an alpha of 0.0836, implying that it can generate a 0.0836 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Quantum BioPharma Price Density |
| Price |
Predictive Modules for Quantum BioPharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Quantum BioPharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Quantum BioPharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Quantum BioPharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Quantum BioPharma is not an exception. The market had few large corrections towards the Quantum BioPharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Quantum BioPharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Quantum BioPharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.08 | |
β | Beta against Dow Jones | 0.82 | |
σ | Overall volatility | 0.85 | |
Ir | Information ratio | 0.01 |
Quantum BioPharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Quantum BioPharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Quantum BioPharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Quantum BioPharma had very high historical volatility over the last 90 days | |
| Quantum BioPharma has a very high chance of going through financial distress in the upcoming years | |
| Quantum BioPharma was previously known as HUGE Old and was traded on NASDAQ Exchange under the symbol HUGE. | |
| Net Loss for the year was (17.9 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Quantum BioPharma generates negative cash flow from operations | |
| Quantum BioPharma has a very weak financial position based on the latest SEC disclosures | |
| About 14.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Mahesh Patel of 16371 shares of Lipocine at 4.86 subject to Rule 16b-3 |
Quantum BioPharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Quantum Stock often depends not only on the future outlook of the current and potential Quantum BioPharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Quantum BioPharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 605.8 K |
Quantum BioPharma Technical Analysis
Quantum BioPharma's future price can be derived by breaking down and analyzing its technical indicators over time. Quantum Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Quantum BioPharma. In general, you should focus on analyzing Quantum Stock price patterns and their correlations with different microeconomic environments and drivers.
Quantum BioPharma Predictive Forecast Models
Quantum BioPharma's time-series forecasting models is one of many Quantum BioPharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Quantum BioPharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Quantum BioPharma
Checking the ongoing alerts about Quantum BioPharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Quantum BioPharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Quantum BioPharma had very high historical volatility over the last 90 days | |
| Quantum BioPharma has a very high chance of going through financial distress in the upcoming years | |
| Quantum BioPharma was previously known as HUGE Old and was traded on NASDAQ Exchange under the symbol HUGE. | |
| Net Loss for the year was (17.9 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Quantum BioPharma generates negative cash flow from operations | |
| Quantum BioPharma has a very weak financial position based on the latest SEC disclosures | |
| About 14.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Mahesh Patel of 16371 shares of Lipocine at 4.86 subject to Rule 16b-3 |
Check out Quantum BioPharma Backtesting, Quantum BioPharma Valuation, Quantum BioPharma Correlation, Quantum BioPharma Hype Analysis, Quantum BioPharma Volatility, Quantum BioPharma History as well as Quantum BioPharma Performance. To learn how to invest in Quantum Stock, please use our How to Invest in Quantum BioPharma guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quantum BioPharma. If investors know Quantum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quantum BioPharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Quantum BioPharma is measured differently than its book value, which is the value of Quantum that is recorded on the company's balance sheet. Investors also form their own opinion of Quantum BioPharma's value that differs from its market value or its book value, called intrinsic value, which is Quantum BioPharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quantum BioPharma's market value can be influenced by many factors that don't directly affect Quantum BioPharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quantum BioPharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Quantum BioPharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quantum BioPharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.